Market Trends Alumis stock rises on Kaken licensing deal (ALMS:NASDAQ)By admin8996erT0allMarch 25, 2025 EonerenShares of Alumis (NASDAQ:ALMS) traded ~14% higher in the premarket on Tuesday after the California-based biopharma announced a collaboration and…
